General Practice Doctors in San Luis, AZ Accepting Medicare

3 General Practice doctors found. Showing 1 - 3

Mr. Jose M Piscoya, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1962 E. Juan Sanchez Bulevard, Suite #1, San Luis, AZ 85349 Phone: 928-722-6098    Fax: 928-627-0007

Danielle Briden, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 815 E Juan Sanchez Blvd, San Luis, AZ 85336 Phone: 928-627-8871

Dr. Elijah Jordan Jr., M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 7125 East Juan Sanchez Blvd, Aspc- Yuma Health Services, San Luis, AZ 85349 Phone: 928-627-8871

News Archive

Health law opponents sharpen fight focus on insurance tax credit

According to news reports, critics have pinpointed this part of the health law in their effort to undo the sweeping overhaul. Meanwhile, USA Today reports that very few middle-income taxpayers will pay more as a result of the measure's taxes, fees and penalties.

Research on bone-derived hormone could lead to new treatments for memory loss, depression

​Researchers from Columbia University Medical Center (CUMC) have found that the skeleton, acting through the bone-derived hormone osteocalcin, exerts a powerful influence on prenatal brain development and cognitive functions such as learning, memory, anxiety, and depression in adult mice.

Sanitation investment in poor countries would yield $9-to-1 benefits in productivity, health and other benefits

Experts estimate that $9 in productivity, health and other benefits are returned for every dollar invested installing toilets for people in countries that today are off-track in meeting the UN Millennium Development Goal (MDG) for sanitation.

EMA CHMP adopts positive opinion for Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

BioPontis Alliance, Merck enter innovative strategic agreement in translational drug research

BioPontis Alliance, LLC announced today that it has entered into an innovative strategic agreement with Merck (known outside the US and Canada as MSD) designed to bridge the gap between early academic discovery science and the development of medicines and technologies that impact human health. The announcement was made this week at the prestigious Partnering For Cures Conference that is convened annually for the purpose of forging strategic cross-sector collaborations.

Read more Medical News

› Verified 6 days ago